Metabolic Reset Semaglutide, a GLP-1 receptor agonist, enhances insulin secretion when necessary, delays gastric emptying, and reduces appetite
While your body can use those amino acids to build its own glutathione, it is a much slower and less efficient process than delivering the whole molecule directly to the cells
Research comparing individuals with type 2 diabetes to healthy controls demonstrated that this hormone enhances insulin secretion in a dose-dependent manner
Ipamorelin is a GHRP that mimics ghrelin to trigger short GH bursts
When to Seek Medical Advice and Safety Precautions Immediate medical attention is required if any of the following occur during GLP-1 agonist treatment: Severe, persistent abdominal pain lasting more than a few hours Abdominal pain accompanied by repeated vomiting that prevents fluid intake Fever alongside severe abdominal pain Abdominal pain that progressively worsens rather than improves Yellowing of the skin or eyes (jaundice) Patients experiencing these symptoms should discontinue their GLP-1 agonist immediately and contact NHS 111, their GP urgently, or attend an emergency department depending on symptom severity
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) increased slightly from September to December 2025 (+5.0%)